NCT00023296View on ClinicalTrials.gov

Nitric Oxide and Transfusion Therapy for Sickle Cell Patients With Pulmonary Hypertension

PHASE1CompletedINTERVENTIONAL
Enrollment

59

Participants

Timeline

Start Date

July 27, 2001

Primary Completion Date

November 2, 2006

Study Completion Date

November 9, 2015

Conditions
Sickle Cell AnemiaPulmonary Hypertension
Interventions
DRUG

Nitric Oxide

DEVICE

INO Pulse - NO Delivery System

Trial Locations (2)

20814

Suburban Hospital, Bethesda

20892

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda

Sponsors

Collaborators (1)

Mallinckrodt
All Listed Sponsors
collaborator

Mallinckrodt

INDUSTRY

lead

National Heart, Lung, and Blood Institute (NHLBI)

NIH